Healthcare M&A is on a healthy pace this year driven in large part by strong interest in specialized outpatient services. Valuations have risen about 31 percent year-to-date over last year, according to LSEG. Due diligence tailored to specific segments is essential given the wide range of potential targets and their highly differentiated characteristics. Here’s an analysis of what’s driving dealflow in this sector and what’s to come in the year ahead.
To read the entire story, you must be logged in.
Please log in now or register with us.
